Factors associated with β-blocker initiation and discontinuation in a population-based cohort of seniors newly diagnosed with heart failure

References

• JencksSFWilliamsMVColemanEARehospitalizations among patients in the Medicare fee-for-service programN Engl J Med2009360141418142819339721
   PubMed Web of Science ®Google Scholar
• MuntwylerJAbetelGGrunerCFollathFOne-year mortality among unselected outpatients with heart failureEur Heart J200223231861186612445535
   PubMed Web of Science ®Google Scholar
• ChowCMDonovanLManuelDJohansenHTuJVCanadian Cardiovascular Outcomes Research TeamRegional variation in self-reported heart disease prevalence in CanadaCan J Cardiol200521141265127116341294
   PubMed Web of Science ®Google Scholar
• ArnoldJMLiuPDemersCCanadian Cardiovascular SocietyCanadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and managementCan J Cardiol2006221234516450016
   PubMed Web of Science ®Google Scholar
• HuntSAAbrahamWTChinMH2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung TransplantationCirculation200911914e391e47919324966
   PubMed Web of Science ®Google Scholar
• JessupMAbrahamWTCaseyDE2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung TransplantationCirculation2009119141977201619324967
   PubMed Web of Science ®Google Scholar
• MaisonPCuninPHemeryFUtilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological studyEur J Clin Pharmacol2005615–644545115940531
   PubMed Web of Science ®Google Scholar
• de GrootePIsnardRAssyagPIs the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO surveyEur J Heart Fail20079121205121118023249
   PubMed Web of Science ®Google Scholar
• LachaineJBeaucheminCRamosEUse, tolerability and compliance of spironolactone in the treatment of heart failureBMC Clin Pharmacol201111421599961
   PubMedGoogle Scholar
• CalvinJEShanbhagSAveryEKaneJRichardsonDPowellLAdherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the heart failure adherence retention trial (HART)Congest Heart Fail2012182737822432552
   PubMedGoogle Scholar
• KomajdaMFollathFSwedbergKThe EuroHeart failure survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 2: treatmentEur Heart J200324546447412633547
   PubMed Web of Science ®Google Scholar
• FonarowGCAbrahamWTAlbertNMDosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from organized program to initiate lifesaving treatment in hospitalized patients with heart failure)Am J Cardiol2008102111524152919026308
   PubMed Web of Science ®Google Scholar
• KrumHNinioDMacDonaldPBaseline predictors of tolerability to carvedilol in patients with chronic heart failureHeart200084661561911083738
   PubMed Web of Science ®Google Scholar
• TamblynRLavoieGPetrellaLMonetteJThe use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in QuebecJ Clin Epidemiol199548899910097775999
   PubMed Web of Science ®Google Scholar
• SchultzSERothwellDMChenZTuKIdentifying cases of congestive heart failure from administrative data: a validation study using primary care patient recordsChronic Dis Inj Can201333316016623735455
   PubMedGoogle Scholar
• KomajdaMLutigerBMadeiraHCARMEN Investigators and Co-ordinatorsTolerability of carvedilol and ACE-inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF Evaluation)Eur J Heart Fail20046446747515182773
   PubMed Web of Science ®Google Scholar
• ShahSMCareyIMDeWildeSRichardsNCookDGTrends and inequities in beta-blocker prescribing for heart failureBr J Gen Pract20085855786286919068160
   PubMed Web of Science ®Google Scholar
• ChatterjeeSBiondi-ZoccaiGAbbateABenefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysisBMJ2013346f5523325883
   PubMed Web of Science ®Google Scholar
• BrophyJMJosephLRouleauJLBeta-blockers in congestive heart failure. A Bayesian meta-analysisAnn Intern Med2001134755056011281737
   PubMed Web of Science ®Google Scholar
• LopponenMRaihaIIsoahoRVahlbergTPuolijokiHKivelaSLDementia associates with undermedication of cardiovascular diseases in the elderly: a population-based studyDement Geriatr Cogn Disord200622213214116741361
   PubMed Web of Science ®Google Scholar
• MaggioniAPSinagraGOpasichCTreatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experienceHeart200389329930512591836
   PubMed Web of Science ®Google Scholar
• RepchinskyCCompendium of Pharmaceuticals and Specialties2012 edOttawa, ONCanadian Pharmacists Association2012
   Google Scholar
• RemmeWJMcMurrayJJHobbsFDSHAPE Study GroupAwareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physiciansEur Heart J200829141739175218506054
   PubMed Web of Science ®Google Scholar
• RuttenFHZuithoffNPHakEGrobbeeDEHoesAWBeta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseaseArch Intern Med20101701088088720498416
   PubMed Web of Science ®Google Scholar
• MasoudiFARathoreSSWangYNational patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunctionCirculation2004110672473115289383
   PubMed Web of Science ®Google Scholar
• KitzmanDWGardinJMGottdienerJSImportance of heart failure with preserved systolic function in patients > or =65 years of age. CHS Research Group. Cardiovascular Health StudyAm J Cardiol200187441341911179524
   PubMed Web of Science ®Google Scholar
• SinDDMcAlisterFAThe effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failureAm J Med2002113865065612505115
   PubMed Web of Science ®Google Scholar
• MaisonPDesamericqGHemeryFRelationship between recommended chronic heart failure treatments and mortality over 8 years in real-world conditions: a pharmacoepidemiological studyEur J Clin Pharmacol201369490190822993100
   PubMed Web of Science ®Google Scholar